The World Hepatitis Summit is a large-scale, global biennial event to advance the viral hepatitis agenda. It is a joint initiative between World Health Organization (WHO) and the World Hepatitis Alliance - in collaboration with a different host country for each Summit.

3 Nov 2017 |

Summit Objectives

The World Hepatitis Summit is a public policy three day event bringing together a global audience of civil society groups, WHO and its Member States, patient organisations from the World Hepatitis Alliance’s 246 organisational members, policy-makers, public health scientists and funders. It aims:

1. To increase the number of countries developing practicable viral hepatitis action plans by making use of the latest public health research and technical support from WHO.

2. To improve the implementation of existing viral hepatitis action plans through the sharing of best practice.

3. To support clause 1.3 of WHO’s Resolution WHA67.6 which urges Member States to “promote the involvement of civil society in all aspects of preventing, diagnosing and treating viral hepatitis”.

4. To discuss funding mechanisms for medicines and/or diagnostics through engagement of key stakeholders.

5. To raise the profile of viral hepatitis by engagement of international top-tier media.

6. To encourage and direct public health research to where it is needed by engaging key global funders.

Click here for more details

Share this on: